Literature DB >> 24815833

Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.

Konstantinos A Bouchagier1, Stelios F Assimakopoulos, Dimitrios D Karavias, Ioannis Maroulis, Vassiliki Tzelepi, Haralabos Kalofonos, Dionissios D Karavias, Dimitrios Kardamakis, Chrisoula D Scopa, Athanassios C Tsamandas.   

Abstract

BACKGROUND: Occludin and claudins are integral constituents of tight junction proteins and are de-regulated in various malignancies, including hepatocellular carcinoma (HCC). This study investigated whether expression of claudins 1, 4, 5, 7 and occludin may be used as prognostic markers for overall and disease-free survival in patients with HCC after hepatectomy. PATIENTS AND METHODS: The study included 67 hepatectomy specimens obtained from an equal number of patients with HCC who underwent partial hepatectomy at the Patras University Hospital for therapeutic reasons. Ten normal liver tissues were used as controls. Expression of claudins 1, 4, 5, 7 and occludin in liver tissues was assessed by immunochemistry. Clinicopathological features were also available for each case.
RESULTS: Expression of claudins 1, 4, 5, 7 and occludin was significantly increased in HCC specimens compared to non-neoplastic liver tissues and normal controls (p<0.001 in each case) Moreover, there was a statistically significant association between low level of claudin-4 and advanced tumor grade (p=0.03). Down-regulation of claudin-1 was associated with low overall survival in univariate survival analysis (p=0.049) and Kaplan-Meier analysis (p=0.04). Multivariate analysis showed that the claudin-4 level was an independent factor for survival prognosis (p=0.01). In addition, down-regulation of claudin-4 expression was associated with increased recurrence rate and low disease-free survival rate in univariate analysis (p=0.038), Kaplan-Meier plot (p=0.013) and multivariate analysis (p=0.013). A low level of claudin-5 and high level of claudin-7 levels were independent negative prognostic factors according to multivariate analysis (p=0.015 and 0.009, respectively).
CONCLUSION: The present study demonstrates that high expression of claudins 1, 4, 5 and down-regulation of claudin-7 are positive prognostic markers and are associated with good outcome and increased survival rates. Moreover, an increase in claudin-4 expression may serve as an independent positive prognostic factor for low recurrence rate after hepatectomy.

Entities:  

Keywords:  Claudins; hepatocellular carcinoma; occludin; tight junction proteins

Mesh:

Substances:

Year:  2014        PMID: 24815833

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  14 in total

1.  Evaluation of clinical significance of claudin 7 and construction of prognostic grading system for stage II colorectal cancer.

Authors:  Ji-Chuan Quan; Jian Peng; Xu Guan; Zheng Liu; Zheng Jiang; Hai-Peng Chen; Meng Zhuang; Song Wang; Peng Sun; Hong-Ying Wang; Shuang-Mei Zou; Xi-Shan Wang
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

2.  Expression of claudin-5, claudin-7 and occludin in oral squamous cell carcinoma and their clinico-pathological significance.

Authors:  Ekarat Phattarataratip; Kraisorn Sappayatosok
Journal:  J Clin Exp Dent       Date:  2016-07-01

3.  Expression of hnRNPK & Claudin-4 in HCV-Induced Early HCC and Adjacent Liver Tissue.

Authors:  Olfat Hammam; Mona Magdy; Amgad Anas; Ali Abdel Rahim; Mohamed Heedaya; Ahmed Helmy
Journal:  Open Access Maced J Med Sci       Date:  2017-07-31

Review 4.  Tight Junction Proteins and the Biology of Hepatobiliary Disease.

Authors:  Natascha Roehlen; Armando Andres Roca Suarez; Houssein El Saghire; Antonio Saviano; Catherine Schuster; Joachim Lupberger; Thomas F Baumert
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

5.  E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions.

Authors:  Perla Yaceli Uc; Jael Miranda; Arturo Raya-Sandino; Lourdes Alarcón; María Luisa Roldán; Rodolfo Ocadiz-Delgado; Enoc Mariano Cortés-Malagón; Bibiana Chávez-Munguía; Georgina Ramírez; René Asomoza; Liora Shoshani; Patricio Gariglio; Lorenza González-Mariscal
Journal:  Int J Oncol       Date:  2020-07-29       Impact factor: 5.650

Review 6.  Tight junction proteins in gastrointestinal and liver disease.

Authors:  Mirjam B Zeisel; Punita Dhawan; Thomas F Baumert
Journal:  Gut       Date:  2018-10-08       Impact factor: 31.793

7.  Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein.

Authors:  Emilie Branche; Stéphanie Conzelmann; Clotilde Parisot; Ludmila Bedert; Pierre L Lévy; Birke Bartosch; Sophie Clément; Francesco Negro
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

8.  Palmitoylated claudin7 captured in glycolipid-enriched membrane microdomains promotes metastasis via associated transmembrane and cytosolic molecules.

Authors:  Florian Thuma; Sarah Heiler; Martina Schnölzer; Margot Zöller
Journal:  Oncotarget       Date:  2016-05-24

Review 9.  Emerging clinical significance of claudin-7 in colorectal cancer: a review.

Authors:  Kun Wang; Chang Xu; Wenjing Li; Lei Ding
Journal:  Cancer Manag Res       Date:  2018-09-20       Impact factor: 3.989

10.  Response to Comment on "Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis".

Authors:  Jung-Soo Pyo; Nae Yu Kim; Won Jin Cho
Journal:  J Pathol Transl Med       Date:  2019-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.